Company · CIK 1517022
Akebia Therapeutics, Inc.
| CIK | 1517022 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | AKBA (Nasdaq) |
| First annual or quarterly report | 2014-05-12 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-281903 | 2024-09-03 | 2025-03-20 | 4 | |
| 333-253539 | 2021-02-25 | 2022-04-28 | 4 | |
| 333-223585 | 2018-03-12 | 2020-05-12 | 7 | |
| 333-211175 | 2016-05-05 | 2017-06-29 | 4 | |
| 333-203206 | 2015-04-02 | 2016-01-08 | 7 | |
| 333-193969 | 2014-02-14 | 2014-03-21 | 7 |
Filings
35| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-03-20 | 424B5Shelf takedown | 333-281903 | 0001193125-25-059312 |
| 2025-03-19 | 424B5Shelf takedown | 333-281903 | 0001193125-25-057843 |
| 2024-09-12 | EFFECTDeclared effective | 333-281903 | 9999999995-24-002822 |
| 2024-09-03 | S-3Shelf registered | 333-281903 | 0001628280-24-039115 |
| 2022-04-28 | EFFECTDeclared effective | 333-253539 | 9999999995-22-001129 |
| 2022-04-07 | 424B5Shelf takedown | 333-253539 | 0001193125-22-098942 |
| 2022-04-07 | 424B5Shelf takedown | 333-253539 | 0001193125-22-098875 |
| 2021-02-25 | S-3ASRShelf registered | 333-253539 | 0001193125-21-057223 |
| 2020-05-12 | 424B5Shelf takedown | 333-223585 | 0001193125-20-140385 |
| 2020-05-11 | 424B5Shelf takedown | 333-223585 | 0001193125-20-139011 |
| 2020-03-12 | 424B5Shelf takedown | 333-223585 | 0001193125-20-071680 |
| 2019-11-12 | 424B5Shelf takedown | 333-223585 | 0001193125-19-290158 |
| 2018-10-30 | EFFECTDeclared effective | 333-227622 | 9999999995-18-002755 |
| 2018-03-26 | 424B5Shelf takedown | 333-223585 | 0001193125-18-096123 |
| 2018-03-22 | 424B5Shelf takedown | 333-223585 | 0001193125-18-092202 |
| 2018-03-12 | S-3ASRShelf registered | 333-223585 | 0001193125-18-079228 |
| 2017-06-29 | 424B5Shelf takedown | 333-211175 | 0001193125-17-218303 |
| 2017-06-28 | 424B5Shelf takedown | 333-211175 | 0001193125-17-216507 |
| 2016-05-20 | EFFECTDeclared effective | 333-211175 | 9999999995-16-004724 |
| 2016-05-05 | S-3Shelf registered | 333-211175 | 0001193125-16-579940 |
| 2016-01-08 | 424B5Shelf takedown | 333-203206 | 0001193125-16-424258 |
| 2016-01-04 | 424B5Shelf takedown | 333-203206 | 0001193125-16-420117 |
| 2015-08-11 | 424B5Shelf takedown | 333-203206 | 0001193125-15-286442 |
| 2015-04-17 | 424B5Shelf takedown | 333-203206 | 0001193125-15-135823 |
| 2015-04-14 | EFFECTDeclared effective | 333-203206 | 9999999995-15-000874 |
| 2015-04-14 | 424B5Shelf takedown | 333-203206 | 0001193125-15-129335 |
| 2015-04-02 | S-3Shelf registered | 333-203206 | 0001193125-15-117982 |
| 2014-03-21 | 424B4Final prospectus | 333-193969 | 0001193125-14-110516 |
| 2014-03-19 | EFFECTDeclared effective | 333-193969 | 9999999995-14-000699 |
| 2014-03-17 | S-1/AAmendment | 333-193969 | 0001193125-14-101166 |
| 2014-03-07 | S-1/AAmendment | 333-193969 | 0001193125-14-089411 |
| 2014-03-07 | S-1/AAmendment | 333-193969 | 0001193125-14-087673 |
| 2014-03-04 | S-1/AAmendment | 333-193969 | 0001193125-14-081000 |
| 2014-02-14 | S-1Registration filed | 333-193969 | 0001193125-14-055104 |
| 2013-12-20 | DRSDraft made public | 377-00412 | 0000950123-13-010530 |